Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Korea Health Industry Development Institute | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Walking is a crucial daily activity that requires complex coordination of muscular systems. It is essential for bone and muscle health, cardiovascular fitness, and activities of daily living, making it an important indicator of prognosis and patient function. Insole gait analysis devices are affordable and easy to use, and they align well with standardized 3D gait analysis. However, their use outside of hospital settings is limited.
This study aims to assess the usability and satisfaction of utilizing insole gait analysis devices for monitoring and providing feedback on the walking status of children with cerebral palsy exhibiting walking impairments in a home environment. Additionally, adherence to a home-based exercise program developed in this study will be evaluated.
The screening test is conducted after obtaining consent, and it involves assessing whether the subject can independently walk more than 10 meters, regardless of the use of assistive devices, following an evaluation of their baseline symptoms and signs.
Subjects who pass the screening test are provided with information about their current walking status and what constitutes normal walking. Following the initial evaluation, they are instructed to participate in the 6-week home exercise program and how to record an exercise log. Additionally, researchers provide participants with an insole gait analysis device and instruct them on its operation, encouraging prolonged usage to ensure that usage time and walking patterns are recorded.
Based on the collected measurement data, feedback is provided over the phone at weeks 3 to 4. After completing the 6-week home exercise program, a final evaluation is conducted in the same manner as the initial evaluation. Satisfaction with the insole gait analysis device is assessed only at the time of the final evaluation.
Usage and satisfaction with the insole gait analysis device will be analyzed, and evaluation indicators will be compared before and after the home exercise program. Additionally, adherence to the home exercise program will be evaluated through exercise logs.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Insole wearing | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Insole wearing | Device | The insole-wearing group is instructed to wear the insole gait analysis device as frequently and for as long as possible during outdoor activities. Participants receive feedback during 3rd to 4th week via telephone. Following a period of 6 weeks, an evaluation of the usability and satisfaction of the insole gait analysis device will be conducted. |
| Measure | Description | Time Frame |
|---|---|---|
| 6-minute Walking Test | This test results will be assessed two times: baseline and after 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Appendicular muscle mass (kg) | This outcome will be measured using bioelectrical impedance. | This test results will be assessed two times: baseline and after 6 weeks |
| Height (cm) | This outcome will be measured using bioelectrical impedance. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Juntaek Hong | Contact | +82 010 6517 7526 | GHDWNSXOR@yuhs.ac | |
| Yerim Do | Contact | +82 010 7154 6011 | doyr62@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Na Young Kim | Severance Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Severance Hospital | Recruiting | Seoul | Seodaemun-gu | 03722 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 3, 2025 | Feb 3, 2025 | Prot_SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D020233 | Gait Disorders, Neurologic |
| D002547 | Cerebral Palsy |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| This test results will be assessed two times: baseline and after 6 weeks |
| Weight (kg) | This outcome will be measured using bioelectrical impedance. | This test results will be assessed two times: baseline and after 6 weeks |
| Grip Strength Test (kg) | This test results will be assessed two times: baseline and after 6 weeks |
| The number of steps (n) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| Calories burned (kcal) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| Activity time (min) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| Activity distance (km) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| Walking speed (m/s) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| Stride length (cm) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| Left-right gait balance (%) | This outcome will be collected using an insole-type gait analyzer. | This test results will be assessed two times: baseline and after 6 weeks |
| 10-meter Walking Test (m/s) | This test results will be assessed two times: baseline and after 6 weeks |
| Pediatric Balance Scale (scores) | The minimum score is 0 points, and the maximum score is 56 points. A higher score indicates better balance ability in children and a greater capacity to perform daily activities independently. | This test results will be assessed two times: baseline and after 6 weeks |
| Gross Motor Function Classification System (levels) | This test results will be assessed two times: baseline and after 6 weeks |
| Korean version of Cerebral Palsy Quality of Life (scores) | If the participant is aged 8 or younger, the relevant questionnaire will be administered; otherwise, the Korean version of KIDSCREEN-52 will be used. The minimum score is 0 points, and the maximum score is 100 points. A higher score indicates a higher quality of life. | This test results will be assessed two times: baseline and after 6 weeks |
| Korean version of KIDSCREEN-52 (Children & Adolescents) (scores) | If the participant is aged over 8, the relevant questionnaire will be administered. The minimum score is 52 points, and the maximum score is 260 points. A higher score indicates a higher quality of life. | This test results will be assessed two times: baseline and after 6 weeks |
| Korean version of KIDSCREEN-52 (Parents) (scores) | The minimum score is 52 points, and the maximum score is 260 points. A higher score indicates a higher quality of life. | This test results will be assessed two times: baseline and after 6 weeks |
| Satisfaction Survey for the Device (scores) | The minimum score is 12, and the maximum score is 84 points. A higher score indicates lower satisfaction. | This test results will be assessed once: after 6 weeks |
| 24812254 | Result | Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2. |
| 15390043 | Result | Stolze H, Klebe S, Baecker C, Zechlin C, Friege L, Pohle S, Deuschl G. Prevalence of gait disorders in hospitalized neurological patients. Mov Disord. 2005 Jan;20(1):89-94. doi: 10.1002/mds.20266. |
| 24132835 | Result | Giladi N, Horak FB, Hausdorff JM. Classification of gait disturbances: distinguishing between continuous and episodic changes. Mov Disord. 2013 Sep 15;28(11):1469-73. doi: 10.1002/mds.25672. |
| 23072296 | Result | Carlon SL, Taylor NF, Dodd KJ, Shields N. Differences in habitual physical activity levels of young people with cerebral palsy and their typically developing peers: a systematic review. Disabil Rehabil. 2013 Apr;35(8):647-55. doi: 10.3109/09638288.2012.715721. Epub 2012 Oct 17. |
| 29423412 | Result | Waltersson L, Rodby-Bousquet E. Physical Activity in Adolescents and Young Adults with Cerebral Palsy. Biomed Res Int. 2017;2017:8080473. doi: 10.1155/2017/8080473. Epub 2017 Dec 20. |
| 31075418 | Result | O'Connell NE, Smith KJ, Peterson MD, Ryan N, Liverani S, Anokye N, Victor C, Ryan JM. Incidence of osteoarthritis, osteoporosis and inflammatory musculoskeletal diseases in adults with cerebral palsy: A population-based cohort study. Bone. 2019 Aug;125:30-35. doi: 10.1016/j.bone.2019.05.007. Epub 2019 May 8. |
| 30221763 | Result | Mcphee PG, Claridge EA, Noorduyn SG, Gorter JW. Cardiovascular disease and related risk factors in adults with cerebral palsy: a systematic review. Dev Med Child Neurol. 2019 Aug;61(8):915-923. doi: 10.1111/dmcn.14028. Epub 2018 Sep 17. |
| 28288745 | Result | Bulekbayeva S, Daribayev Z, Ospanova S, Vento S. Cerebral palsy: a multidisciplinary, integrated approach is essential. Lancet Glob Health. 2017 Apr;5(4):e401. doi: 10.1016/S2214-109X(17)30082-7. No abstract available. |
| 24556672 | Result | Muro-de-la-Herran A, Garcia-Zapirain B, Mendez-Zorrilla A. Gait analysis methods: an overview of wearable and non-wearable systems, highlighting clinical applications. Sensors (Basel). 2014 Feb 19;14(2):3362-94. doi: 10.3390/s140203362. |
| 31141973 | Result | Ngueleu AM, Blanchette AK, Maltais D, Moffet H, McFadyen BJ, Bouyer L, Batcho CS. Validity of Instrumented Insoles for Step Counting, Posture and Activity Recognition: A Systematic Review. Sensors (Basel). 2019 May 28;19(11):2438. doi: 10.3390/s19112438. |
| 26971404 | Result | Andreoli A, Garaci F, Cafarelli FP, Guglielmi G. Body composition in clinical practice. Eur J Radiol. 2016 Aug;85(8):1461-8. doi: 10.1016/j.ejrad.2016.02.005. Epub 2016 Feb 15. |
| 34233405 | Result | Lee SY. Handgrip Strength: An Irreplaceable Indicator of Muscle Function. Ann Rehabil Med. 2021 Jun;45(3):167-169. doi: 10.5535/arm.21106. Epub 2021 Jun 30. No abstract available. |
| 24239880 | Result | Chrysagis N, Skordilis EK, Koutsouki D. Validity and clinical utility of functional assessments in children with cerebral palsy. Arch Phys Med Rehabil. 2014 Feb;95(2):369-74. doi: 10.1016/j.apmr.2013.10.025. Epub 2013 Nov 12. |
| D001925 | Brain Damage, Chronic |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |